Javier Ros

27PUBLICATIONS
87CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)Predictive and prognostic markersCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|May 04, 2026
Genomic Landscape, Targeted Therapies, and Mechanisms of Resistance in Molecularly Selected Metastatic Colorectal Cancer Patients.

|Dec 04, 2025
Mosperafenib, a Novel Paradox-Breaker BRAF Inhibitor with Potent Preclinical Activity in BRAF-Mutated Colorectal Cancer.

Florian Renner, Jan Eckmann, Cornelia Handl

|Jan 08, 2025
Real-World Data of Patients with BRAF V600E-Mutated Metastatic Colorectal Cancer Treated with Trifluridine/Tipiracil.

Javier Ros, Jose Maria Ucha, Eduardo Garcia-Galea

|Jul 17, 2024
Precision Oncology and Systemic Targeted Therapy in Pseudomyxoma Peritonei.

Jordi Martínez-Quintanilla, Débora Cabot, Doménico Sabia

|Jul 13, 2024
Current and Emerging Treatment Paradigms in Colorectal Cancer: Integrating Hallmarks of Cancer.

Clara Salva de Torres, Iosune Baraibar, Nadia Saoudi González

|May 22, 2024
Epidermal growth factor receptor antagonists in colorectal cancer: emerging strategies for precision therapy.

Nadia Saoudi González, Paola Valeria Marchese, Iosune Baraibar

Pageof 5

Frequent Collaborators

13 joint publications

Iosune Baraibar

13 joint publications

Josep Tabernero

9 joint publications

Elena Elez

5 joint publications

Marta Rodríguez-Castells